Last visit characteristics | Overall (N = 193) | Retained (R) (N = 59) | Discharged (D/C) (N = 46) | Defaulted (DF) (N = 88) | Overall p-value | R vs. D/C | R vs. DF | D/C vs. DF |
---|---|---|---|---|---|---|---|---|
Macrovascular complications | ||||||||
CAD (%) | 45 (23.8) | 17 (29.3) | 9 (20.0) | 19 (22.1) | 0.4802 | |||
PVD (%) | 14 (7.5) | 6 (10.2) | 1 (2.3) | 7 (8.2) | 0.3081 | |||
CVA/TIA (%) | 12 (6.3) | 7 (12.1) | 1 (2.2) | 4 (4.6) | 0.1305 | 0.1336 | 0.1164 | 0.4980 |
Any macrovascular complications (%) | 57 (30.0) | 23 (39.0) | 10 (22.2) | 24 (27.9) | 0.1539 | |||
Microvascular complications | ||||||||
Nephropathy (%) | 65 (35.7) | 24 (40.7) | 11 (25.6) | 30 (37.5) | 0.2635 | |||
Retinopathy (%) | 31 (18.8) | 14 (25.6) | 2 (5.1) | 15 (21.7) | 0.0406 | 0.0121 | 0.7080 | 0.0228 |
Neuropathy (%) | 50 (27.3) | 15 (25.9) | 7 (15.9) | 28 (34.6) | 0.0785 | 0.2261 | 0.2735 | 0.0265 |
Any microvascular complications (%) | 95 (53.7) | 31 (53.5) | 16 (37.2) | 48 (63.2) | 0.0243 | 0.1057 | 0.2576 | 0.0064 |
Disease status (last visit): | ||||||||
HbA1c (%)(mean, SD) | 7.6 (1.6) | 7.8 (1.8) | 6.6 (0.9) | 7.9 (1.5) | <0.0001 | <0.0001 | 0.7069 | <0.0001 |
HbA1c (IFCC units mmol/mol) | 60 | 62 | 49 | 63 | ||||
HbA1c ≤ 7.0% or 53 mmol/mol (%) | 86 (46.2) | 25 (42.4) | 37 (84.1) | 24 (28.9) | <0.0001 | <0.0001 | 0.0964 | <0.0001 |
Change in HbA1c (%) (mean, SD) | −0.90 (1.7) | −0.74 (1.75) | −1.28 (1.87) | −0.80 (1.69) | 0.2480 | |||
Weight (kg) (mean, SD) | 94.5 (23.3) | 94.3 (21.8) | 88.8 (21.2) | 97.6 (25.0) | 0.1289 | 0.2074 | 0.4183 | 0.0495 |
Change in weight (mean, SD) | 0.8 (5.1) | 1.6 (5.6) | 0.3 (5.3) | 0.4 (4.7) | 0.2978 | |||
BMI | 33.9 (7.7) | 34.2 (7.4) | 32.5 (7.2) | 34.5 (8.2) | 0.3726 | |||
SBP (mean, SD) | 139.2 (19.8) | 141.7 (21.8) | 133.4 (17.9) | 140.5 (18.9) | 0.0712 | 0.0390 | 0.7263 | 0.0376 |
DBP (mean, SD) | 73.1 (9.6) | 71.8 (9.6) | 72.4 (10.4) | 74.2 (9.1) | 0.2828 | |||
Total Chol (mean, SD) | 4.5 (1.4) | 4.4 (1.2) | 4.4 (1.1) | 4.7 (1.6) | 0.2377 | |||
HDL-C (mean, SD) | 1.2 (0.3) | 1.1 (0.3) | 1.2 (0.3) | 1.2 (0.3) | 0.6053 | |||
LDL-C (mean, SD) | 2.3 (1.0) | 2.4(1.0) | 2.3 (1.0) | 2.3 (1.0) | 0.8984 | |||
Triglycerides (median, QR) | 1.8 (1.2–2.7) | 1.7 (1.3–2.5) | 1.8 (1.2–2.5) | 1.9 (1.3–3.2) | 0.3467 | |||
TC:HDL-C (mean, SD) | 4.1 (1.4) | 4.03 (1.2) | 3.82 (1.2) | 4.31 (1.6) | 0.1874 | |||
Smoker (%) | 33 (18.8) | 6 (10.9) | 7 (16.3) | 20 (25.6) | 0.0897 | 0.4367 | 0.0349 | 0.2365 |
Last visit medications: | ||||||||
On insulin (%) | 75 (38.9) | 37 (62.7) | 7 (15.2) | 31 (35.2) | <0.0001 | <0.0001 | 0.0011 | 0.0147 |
On ACE-I/ARB (%) | 144 (74.6) | 48 (81.4) | 33 (71.7) | 63 (71.6) | 0.3604 | |||
On ASA (%) | 94 (48.7) | 37 (62.7) | 20 (43.5) | 37 (42.1) | 0.0351 | 0.0497 | 0.0140 | 0.8734 |
On Statin (%) | 146 (75.7) | 49 (83.1) | 37 (80.4) | 60 (68.2) | 0.0825 | 0.7297 | 0.0436 | 0.1320 |
Clinic activity | ||||||||
Median duration of follow-up (months) | 16 (6 to 31) | 33(31 to 35) | 10 (4 to 18) | 9 (5 to 17) | <0.0001 | <0.0001 | <0.0001 | 0.8827 |
% of MD visits where meds changed (Mean, SD) | 48.7 (30.0) | 55.2 (23.1) | 34.4 (25.7) | 51.8 (33.9) | 0.0007 | <0.0001 | 0.5037 | 0.0027 |
% of patient encounters that were no-shows (Median, IQR) | 14.3 (0 to 33.3) | 8.3 (0 to 16.7) | 0 (0 to 14.3) | 30 (13.8 to 50.0) | <0.0001 | 0.1112 | <0.0001 | <0.0001 |
Number of visits with MD (mean, SD) | 4.9 (3.1) | 8.1 (2.8) | 3.3 (1.9) | 3.7 (2.0) | <0.0001 | <0.0001 | <0.0001 | 0.2907 |
Number of visits with RN (mean, SD) | 2.5 (2.1) | 3.7 (2.6) | 2.1 (1.7) | 2.0 (1.7) | <0.0001 | 0.0006 | <0.0001 | 0.6919 |
Number of visits with RD (mean, SD) | 2.4 (2.0) | 3.5 (2.5) | 2.2 (1.9) | 1.7 (1.3) | <0.0001 | 0.0036 | <0.0001 | 0.1053 |